Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2007 1
2010 1
2014 1
2017 2
2019 1
2020 1
2021 2
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Dearani JA, Rowin EJ, Maron MS, Sherrid MV. Maron BJ, et al. J Am Coll Cardiol. 2022 Feb 1;79(4):390-414. doi: 10.1016/j.jacc.2021.11.021. J Am Coll Cardiol. 2022. PMID: 35086661 Free article.
Hypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited primary cardiac disease, has now transformed into a contemporary highly treatable condition with effective options that alter natural history along specific personalize …
Hypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited primary cardiac disease, has now transform …
Hypertrophic cardiomyopathy: a systematic review.
Maron BJ. Maron BJ. JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308. JAMA. 2002. PMID: 11886323 Review.
Subsets with higher mortality or morbidity are linked to the complications of sudden death, progressive heart failure, and atrial fibrillation with embolic stroke. Treatment strategies depend on appropriate patient selection, including drug treatment for exertional …
Subsets with higher mortality or morbidity are linked to the complications of sudden death, progressive heart failure, and atr …
Efficacy of peritoneal dialysis in patients with refractory congestive heart failure: a systematic review and meta-analysis.
Timóteo AT, Mano TB. Timóteo AT, et al. Heart Fail Rev. 2023 Sep;28(5):1053-1063. doi: 10.1007/s10741-023-10297-3. Epub 2023 Feb 4. Heart Fail Rev. 2023. PMID: 36738391 Free PMC article. Review.
Refractory congestive heart failure (RCHF) is a common complication in the natural history of advanced heart failure. ...
Refractory congestive heart failure (RCHF) is a common complication in the natural history of advanced …
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.
Lago RM, Singh PP, Nesto RW. Lago RM, et al. Lancet. 2007 Sep 29;370(9593):1129-36. doi: 10.1016/S0140-6736(07)61514-1. Lancet. 2007. PMID: 17905165 Review.
BACKGROUND: The overall clinical benefit of thiazolidinediones (TZDs) as a treatment for hyperglycaemia can be difficult to assess because of the risk of congestive heart failure due to TZD-related fluid retention. Since prediabetic and diabetic patients are …
BACKGROUND: The overall clinical benefit of thiazolidinediones (TZDs) as a treatment for hyperglycaemia can be difficult to assess because o …
Natural History of Asymptomatic Severe Aortic Stenosis and the Association of Early Intervention With Outcomes: A Systematic Review and Meta-analysis.
Gahl B, Çelik M, Head SJ, Vanoverschelde JL, Pibarot P, Reardon MJ, van Mieghem NM, Kappetein AP, Jüni P, da Costa BR. Gahl B, et al. JAMA Cardiol. 2020 Oct 1;5(10):1102-1112. doi: 10.1001/jamacardio.2020.2497. JAMA Cardiol. 2020. PMID: 32639521 Free PMC article.
IMPORTANCE: Whether intervention should be performed in patients with asymptomatic severe aortic stenosis (AS) remains debated. OBJECTIVE: To meta-analyze the natural history of asymptomatic severe AS and examine the association of early intervention with survival. …
IMPORTANCE: Whether intervention should be performed in patients with asymptomatic severe aortic stenosis (AS) remains debated. OBJECTIVE: T …
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J. Clegg AJ, et al. Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450. Health Technol Assess. 2005. PMID: 16303098 Free article. Review.
OBJECTIVES: To assess the clinical and cost-effectiveness of left ventricular assist devices (LVADs) as a bridge to heart transplantation (BTT), as a bridge to myocardial recovery (BTR) or as a long-term chronic support (LTCS) for people with end-stage heart fail …
OBJECTIVES: To assess the clinical and cost-effectiveness of left ventricular assist devices (LVADs) as a bridge to heart transplanta …
Mode of Death in Heart Failure With Preserved Ejection Fraction.
Vaduganathan M, Patel RB, Michel A, Shah SJ, Senni M, Gheorghiade M, Butler J. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Feb 7;69(5):556-569. doi: 10.1016/j.jacc.2016.10.078. J Am Coll Cardiol. 2017. PMID: 28153111 Free article. Review.
Little is known about specific modes of death in patients with heart failure with preserved ejection fraction (HFpEF). Herein, the authors critically appraise the current state of data and offer potential future directions. ...There is an unmet need for a longitudin …
Little is known about specific modes of death in patients with heart failure with preserved ejection fraction (HFpEF). Herein, …
Clinical significance of chronic myocarditis: systematic review and meta-analysis.
Hirono K, Takarada S, Okabe M, Miyao N, Nakaoka H, Ibuki K, Ozawa S, Origasa H, Ichida F, Imanaka-Yoshida K. Hirono K, et al. Heart Vessels. 2022 Feb;37(2):300-314. doi: 10.1007/s00380-021-01914-y. Epub 2021 Aug 7. Heart Vessels. 2022. PMID: 34365565
Primary outcome of this study was to assess the efficacy of immunomodulatory treatment in addition to conventional treatment, and secondary outcomes were to clarity the prognosis of natural history of chronic myocarditis and incidence of chronic myocarditis in patie …
Primary outcome of this study was to assess the efficacy of immunomodulatory treatment in addition to conventional treatment, and secondary …
Unicuspid aortic valve in children: a systematic review spanning four decades.
Mookadam F, Thota VR, Lopez AM, Emani UR, Tajik AJ. Mookadam F, et al. J Heart Valve Dis. 2010 Nov;19(6):678-83. J Heart Valve Dis. 2010. PMID: 21214089 Review.
BACKGROUND AND AIM OF THE STUDY: To date, the natural history of the unicuspid aortic valve (UAV) has been poorly described in the literature. ...The mean age at diagnosis was 14 months, the most common presentation of UAV was congestive heart failu …
BACKGROUND AND AIM OF THE STUDY: To date, the natural history of the unicuspid aortic valve (UAV) has been poorly described in …
Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies.
El Dib R, Gomaa H, Ortiz A, Politei J, Kapoor A, Barreto F. El Dib R, et al. PLoS One. 2017 Mar 15;12(3):e0173358. doi: 10.1371/journal.pone.0173358. eCollection 2017. PLoS One. 2017. PMID: 28296917 Free PMC article. Review.
BACKGROUND: Anderson-Fabry disease (AFD) is an X-linked recessive inborn error of glycosphingolipid metabolism caused by a deficiency of alpha-galactosidase A. Renal failure, heart and cerebrovascular involvement reduce survival. A Cochrane review provided little ev …
BACKGROUND: Anderson-Fabry disease (AFD) is an X-linked recessive inborn error of glycosphingolipid metabolism caused by a deficiency of alp …
15 results